Medtech and biotech stakeholders have a major role to play in achieving the UN Sustainable Development Goals (SDGs).
That’s the message from the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital Global Health.
“Each of the 17 SDGs outlines strategies to end extreme poverty, inequality and climate change by 2030. Building on the progress made by the Millennium Development Goals, the SDGs prioritise people, planet, prosperity, peace and partnership to build a more sustainable world. The SDGs implicate all countries and all stakeholders and call upon industry leaders to address these initiatives,” said Nicholas Diamond, MPH, is the Marketing and Communications Manager (CAMTech).
Writing in our upcoming special edition on biotechnology, which will be distributed at the IBioIC conference in Glasgow, Nicholas urges delegates to turn their attention to the SDGs.
“Using a biotech approach to advance population health is crosscutting and aligns with nearly all 17 SDGs. As thought leaders gather at IBiolC two years after implementing the SDGs, the conversation should address meeting the SDGs using both inclusionary medtech and participatory biotech.”
The full article from Nicholas will be available in the biotech edition, which is out later this month.
